Synergistic chemotherapy and photothermal therapy of lung cancer using MoS2 nanosheets co-loaded with silybin and doxorubicin

• Published in: Alexandria engineering journal Vol. 106; pp. 767 - 777
• Main Authors: Wang, Zhenjun, Xie, Zongtao, Liu, Chuanxin, Zhang, Xiaojun
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.11.2024; Elsevier
• Subjects: Drug Delivery Systems; MoS2 Nanocarriers; Nanomedicine; Photothermal Therapy; Synergistic Chemotherapy; Tumor Targeting; Photothermal Therapy; Synergistic Chemotherapy; Nanomedicine; MoS2 Nanocarriers; Tumor Targeting; Drug Delivery Systems

The active ingredient in traditional Chinese medicine, silybin (SBN), is known to inhibit the proliferation of cancer cells and synergistically enhance the anticancer effects of the chemotherapy drug doxorubicin (DOX). However, the combination of SBN and DOX faces challenges such as a lack of target...